Prof. Angela Russell

Professor of Medicinal Chemistry, Oxford University

Angela Russell is a medicinal chemist based in the Departments of Chemistry and Pharmacology at the University of Oxford. Her research interests are centred around the discovery of new molecules and mechanisms to manipulate cell fate and to translate them into therapeutic agents for degenerative diseases and cancers.

Dr. Claire Wells

Reader in cancer cell biology at Kings College, London

Claire Wells obtained her undergraduate degree in Biology from University College London and undertook a PhD degree in muscle cell biology focusing on cell migration studies at the MRC Randall Institute London with Prof. Michelle Peckham and Prof. Graham Dunn. Subsequently she moved to the field of cancer cell metastasis first with postdoctoral studies in the laboratory of Prof. Anne Ridley at the Ludwig Institute London and subsequently in the laboratory of Prof. Gareth Jones at Kings College London. Claire established her own group studying metastatic disease at Kings College London in 2007, with a particular emphasis on the role of PAK family kinases in inflammation and cancer. Her work has been recognised by Cancer Research Technology as a target for therapeutic intervention and she has published primary research papers and peer reviewed articles in the field of molecular pathways that regulate cell migration and invasion.

Prof. Ramsey Cutress

Professor of Breast Surgery and Consultant Breast Surgeon, Southampton University Hospital

Ramsey Cutress is Professor of Breast Surgery at the University of Southampton, Consultant Surgeon and Clinical Lead for Breast Surgery at Southampton University Hospitals Trust and the University of Southampton lead for the Wessex Academic Foundation Programme. His clinical research interests include breast cancer in young women as a member of the POSH study research team and the investigation of patient and host determinants of breast cancer outcomes including genetic predisposition, immunological and lifestyle factors. Ramsey was a member of the writing group for the NICE Early and Locally Advanced Breast Cancer Guideline (NG101), and is currently involved in various national research studies, clinical trials including as Co-CI of the EndoNET HTA funded trial of neo-adjuvant endocrine therapy, and translational projects. He is Chair of the Academic and Research Committee of the Association of Breast Surgery (ABS) and breast sub-specialty editor for the Annals of the Royal College of Surgeons.

Prof. Christoph Wülfing

Professor of Immunology, Bristol University

Christoph Wülfing has obtained his undergraduate degree in Chemistry at the Ludwigs-Maximilians-University of Munich and a PhD degree in Biochemistry at the Max-Planck-Institute for Biochemistry in Martinsried. After postdoctoral studies in molecular immunology in the laboratory of Dr. Mark M. Davis at Stanford University, he established his own group in 2000 at the UT Southwestern Medical Center in Dallas to focus on large-scale imaging of signal transduction to elucidate mechanisms of T cell function. In 2012 he moved to his current position as Professor of Immunology at the University of Bristol, where he is now extending imaging approaches to the suppression of cytotoxic T cells by tumours.

Dr. Kostas Tsilidis

Senior lecturer in Cancer Epidemiology, Imperial College London

Dr. Tsilidis is a Senior Lecturer in Cancer Epidemiology at Imperial College London. He also holds an Associate Professor position in Epidemiology at the University of Ioannina School of Medicine in Greece, and a honorary Senior Lecturer position at the University of Bristol. He is a molecular epidemiologist with a strong focus on cancer aetiology and prevention. He has written more than 180 scientific papers published in international high-impact journals, and has received more than 8,000 citations. He is the PI of the Epirus Health Study, an ongoing highly-phenotyped cohort in Greece. Since January 2020, he is the co-head of the World Cancer Research Fund Continuous Update Project team at Imperial College London, where he leads the regular review of the epidemiological literature on the role of diet, nutrition, anthropometric characteristics and physical activity on cancer prevention and prognosis. 

Prof. Jo Morris

Professor Jo Morris is based at the University of Birmingham, Cancer and Genomics Department with a primary interest in how cells maintain and repair our DNA. Prof Morris investigates proteins involved in DNA replication and repair including the breast and ovarian predisposition protein BRCA1.

Dr Cathy Merry

Dr Cathy Merry is based in the Centre for Stem Cells, Tissue Engineering and Modelling (STEM) at the University of Nottingham where her Stem Cell Glycobiology Group work to uncover the role of complex sugars (glycosaminoglycans or GAGs) in controlling cell behaviour.

Professor Joy Burchell

Professor Joy Burchell is a glyco-oncologist of The Breast Cancer Biology Group at Kings College London and studies the molecular and phenotypic changes that occur in breast cancer with the aim of translating the findings into clinical applications.

Professor Ruth Muschel

Professor Ruth Muschel is Deputy Director of the CRUK/MRC Oxford Institute of Radiation Oncology and Professor of Molecular Pathology at the University of Oxford.

Sarah Crane

Research Advocate

Sarah Crane is Chief Executive of The Pelican Cancer Foundation.